HEADER TRANSCRIPTION/TRANSCRIPTION INHIBITOR 27-DEC-13 4O8F TITLE CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PPARGAMMA MUTANT R357A AND TITLE 2 ROSIGLITAZONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: PPAR-GAMMA, NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 3; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1C3, PPARG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS BUNDLE OF ALPHA-HELICES, SMALL FOUR-STRANDED BETA-SHEET, KEYWDS 2 TRANSCRIPTION FACTOR, RXRALPHA, TRANSCRIPTION-TRANSCRIPTION KEYWDS 3 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR G.POCHETTI,R.MONTANARI,D.CAPELLI,R.CHIARALUCE,V.CONSALVI,C.LORI, AUTHOR 2 F.LOIODICE,A.LAGHEZZA,A.PASQUO,L.CERVONI,M.ASCHI REVDAT 3 20-SEP-23 4O8F 1 REMARK SEQADV REVDAT 2 17-JUL-19 4O8F 1 REMARK REVDAT 1 23-JUL-14 4O8F 0 JRNL AUTH C.LORI,A.PASQUO,R.MONTANARI,D.CAPELLI,V.CONSALVI, JRNL AUTH 2 R.CHIARALUCE,L.CERVONI,F.LOIODICE,A.LAGHEZZA,M.ASCHI, JRNL AUTH 3 A.GIORGI,G.POCHETTI JRNL TITL STRUCTURAL BASIS OF THE TRANSACTIVATION DEFICIENCY OF THE JRNL TITL 2 HUMAN PPAR GAMMA F360L MUTANT ASSOCIATED WITH FAMILIAL JRNL TITL 3 PARTIAL LIPODYSTROPHY. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 70 1965 2014 JRNL REFN ISSN 0907-4449 JRNL PMID 25004973 JRNL DOI 10.1107/S1399004714009638 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.MONTANARI,F.SACCOCCIA,E.SCOTTI,M.CRESTANI,C.GODIO, REMARK 1 AUTH 2 F.GILARDI,F.LOIODICE,G.FRACCHIOLLA,A.LAGHEZZA,P.TORTORELLA, REMARK 1 AUTH 3 A.LAVECCHIA,E.NOVELLINO,F.MAZZA,M.ASCHI,G.POCHETTI REMARK 1 TITL CRYSTAL STRUCTURE OF THE PEROXISOME PROLIFERATOR-ACTIVATED REMARK 1 TITL 2 RECEPTOR GAMMA (PPARGAMMA) LIGAND BINDING DOMAIN COMPLEXED REMARK 1 TITL 3 WITH A NOVEL PARTIAL AGONIST: A NEW REGION OF THE REMARK 1 TITL 4 HYDROPHOBIC POCKET COULD BE EXPLOITED FOR DRUG DESIGN. REMARK 1 REF J.MED.CHEM. V. 51 7768 2008 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 19053776 REMARK 1 DOI 10.1021/JM800733H REMARK 1 REFERENCE 2 REMARK 1 AUTH R.T.NOLTE,G.B.WISELY,S.WESTIN,J.E.COBB,M.H.LAMBERT, REMARK 1 AUTH 2 R.KUROKAWA,M.G.ROSENFELD,T.M.WILLSON,C.K.GLASS,M.V.MILBURN REMARK 1 TITL LIGAND BINDING AND CO-ACTIVATOR ASSEMBLY OF THE PEROXISOME REMARK 1 TITL 2 PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA. REMARK 1 REF NATURE V. 395 137 1998 REMARK 1 REFN ISSN 0028-0836 REMARK 1 PMID 9744270 REMARK 1 DOI 10.1038/25931 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.4_1496 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 61.09 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 18946 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.241 REMARK 3 R VALUE (WORKING SET) : 0.234 REMARK 3 FREE R VALUE : 0.297 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.060 REMARK 3 FREE R VALUE TEST SET COUNT : 1906 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 61.1048 - 6.2644 0.98 1295 144 0.2008 0.2351 REMARK 3 2 6.2644 - 4.9729 0.98 1250 138 0.2356 0.2693 REMARK 3 3 4.9729 - 4.3445 1.00 1237 135 0.2039 0.2667 REMARK 3 4 4.3445 - 3.9474 0.97 1209 139 0.2174 0.2988 REMARK 3 5 3.9474 - 3.6645 0.99 1226 138 0.2260 0.3093 REMARK 3 6 3.6645 - 3.4485 0.99 1224 137 0.2467 0.3450 REMARK 3 7 3.4485 - 3.2758 0.99 1215 137 0.2689 0.3431 REMARK 3 8 3.2758 - 3.1332 0.96 1178 129 0.2791 0.3378 REMARK 3 9 3.1332 - 3.0126 0.98 1199 137 0.2815 0.4069 REMARK 3 10 3.0126 - 2.9086 0.99 1187 133 0.2728 0.3243 REMARK 3 11 2.9086 - 2.8177 1.00 1236 140 0.2882 0.3973 REMARK 3 12 2.8177 - 2.7371 1.00 1204 139 0.2914 0.3809 REMARK 3 13 2.7371 - 2.6651 0.98 1182 132 0.2842 0.3400 REMARK 3 14 2.6651 - 2.6000 0.97 1198 128 0.3015 0.3565 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.440 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 33.360 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 57.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.011 4122 REMARK 3 ANGLE : 1.602 5556 REMARK 3 CHIRALITY : 0.054 641 REMARK 3 PLANARITY : 0.008 702 REMARK 3 DIHEDRAL : 16.757 1558 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4O8F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-JAN-14. REMARK 100 THE DEPOSITION ID IS D_1000084172. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-DEC-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18994 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 81.920 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.06100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.72 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.43500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 2PRG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.38 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MORPHEUS A5: 10% W/V PEG 20 000, 20% REMARK 280 V/V PEG MME 550, 0.1 M MOPS/HEPES-NA, PH 7.5, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.90000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 81.90000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 42.85000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 43.55000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 42.85000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 43.55000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 81.90000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 42.85000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 43.55000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 81.90000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 42.85000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 43.55000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 191 REMARK 465 SER A 192 REMARK 465 HIS A 193 REMARK 465 MET A 194 REMARK 465 ALA A 195 REMARK 465 GLU A 196 REMARK 465 ILE A 197 REMARK 465 SER A 198 REMARK 465 SER A 199 REMARK 465 ASP A 200 REMARK 465 ILE A 201 REMARK 465 ASP A 202 REMARK 465 GLN A 203 REMARK 465 LEU A 204 REMARK 465 ASN A 205 REMARK 465 PRO A 206 REMARK 465 THR A 242 REMARK 465 ASP A 243 REMARK 465 LYS A 244 REMARK 465 LYS A 261 REMARK 465 ILE A 262 REMARK 465 LYS A 263 REMARK 465 PHE A 264 REMARK 465 LYS A 265 REMARK 465 HIS A 266 REMARK 465 ILE A 267 REMARK 465 GLN A 271 REMARK 465 GLU A 272 REMARK 465 GLN A 273 REMARK 465 SER A 274 REMARK 465 LYS A 275 REMARK 465 THR A 461 REMARK 465 ASP A 462 REMARK 465 MET A 463 REMARK 465 SER A 464 REMARK 465 GLY B 191 REMARK 465 SER B 192 REMARK 465 HIS B 193 REMARK 465 MET B 194 REMARK 465 ALA B 195 REMARK 465 GLU B 196 REMARK 465 ILE B 197 REMARK 465 SER B 198 REMARK 465 SER B 199 REMARK 465 ASP B 200 REMARK 465 ILE B 201 REMARK 465 ASP B 202 REMARK 465 GLN B 203 REMARK 465 LEU B 204 REMARK 465 ASN B 205 REMARK 465 PRO B 206 REMARK 465 LYS B 263 REMARK 465 PHE B 264 REMARK 465 LYS B 265 REMARK 465 HIS B 266 REMARK 465 ILE B 267 REMARK 465 THR B 268 REMARK 465 PRO B 269 REMARK 465 LEU B 270 REMARK 465 GLN B 271 REMARK 465 GLU B 272 REMARK 465 GLN B 273 REMARK 465 SER B 274 REMARK 465 LYS B 275 REMARK 465 LYS B 457 REMARK 465 LYS B 458 REMARK 465 THR B 459 REMARK 465 GLU B 460 REMARK 465 THR B 461 REMARK 465 ASP B 462 REMARK 465 MET B 463 REMARK 465 SER B 464 REMARK 465 LEU B 465 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 335 -166.54 -126.58 REMARK 500 SER A 342 86.90 49.17 REMARK 500 GLU A 343 26.51 40.92 REMARK 500 PHE A 360 -142.67 -95.11 REMARK 500 ASP A 362 23.03 -145.16 REMARK 500 GLU A 378 36.27 73.32 REMARK 500 ASP A 396 21.65 -150.20 REMARK 500 THR A 459 -56.48 64.75 REMARK 500 PRO A 467 -71.23 -19.66 REMARK 500 ASP A 475 16.37 54.19 REMARK 500 THR B 238 -164.94 -78.01 REMARK 500 THR B 242 46.93 -73.20 REMARK 500 ASP B 243 -36.07 -162.51 REMARK 500 ASP B 251 -155.05 -171.71 REMARK 500 GLU B 259 -35.56 -34.62 REMARK 500 LYS B 261 -37.38 -130.55 REMARK 500 ASP B 310 137.35 -20.21 REMARK 500 SER B 342 78.66 39.94 REMARK 500 SER B 355 68.54 -109.99 REMARK 500 LYS B 358 -161.32 58.87 REMARK 500 SER B 394 -80.19 -59.33 REMARK 500 ASP B 396 18.19 -161.97 REMARK 500 LYS B 474 117.51 -21.96 REMARK 500 ASP B 475 66.49 -21.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BRL A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BRL B 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4L98 RELATED DB: PDB REMARK 900 PPARGAMMA MUTANT F360L COMPLEXED WITH LT175 (SP. GR. P21212) REMARK 900 RELATED ID: 4L96 RELATED DB: PDB REMARK 900 PPARGAMMA MUTANT F360L COMPLEXED WITH LT175 (SP. GR. I222) REMARK 900 RELATED ID: 2PRG RELATED DB: PDB REMARK 900 PPARGAMMA WT COMPLEXED WITH ROSIGLITAZONE REMARK 900 RELATED ID: 3B3K RELATED DB: PDB REMARK 900 PPARGAMMA WT COMPLEXED WITH LT175 DBREF 4O8F A 195 477 UNP P37231 PPARG_HUMAN 223 505 DBREF 4O8F B 195 477 UNP P37231 PPARG_HUMAN 223 505 SEQADV 4O8F GLY A 191 UNP P37231 EXPRESSION TAG SEQADV 4O8F SER A 192 UNP P37231 EXPRESSION TAG SEQADV 4O8F HIS A 193 UNP P37231 EXPRESSION TAG SEQADV 4O8F MET A 194 UNP P37231 EXPRESSION TAG SEQADV 4O8F ALA A 357 UNP P37231 ARG 385 ENGINEERED MUTATION SEQADV 4O8F GLY B 191 UNP P37231 EXPRESSION TAG SEQADV 4O8F SER B 192 UNP P37231 EXPRESSION TAG SEQADV 4O8F HIS B 193 UNP P37231 EXPRESSION TAG SEQADV 4O8F MET B 194 UNP P37231 EXPRESSION TAG SEQADV 4O8F ALA B 357 UNP P37231 ARG 385 ENGINEERED MUTATION SEQRES 1 A 287 GLY SER HIS MET ALA GLU ILE SER SER ASP ILE ASP GLN SEQRES 2 A 287 LEU ASN PRO GLU SER ALA ASP LEU ARG ALA LEU ALA LYS SEQRES 3 A 287 HIS LEU TYR ASP SER TYR ILE LYS SER PHE PRO LEU THR SEQRES 4 A 287 LYS ALA LYS ALA ARG ALA ILE LEU THR GLY LYS THR THR SEQRES 5 A 287 ASP LYS SER PRO PHE VAL ILE TYR ASP MET ASN SER LEU SEQRES 6 A 287 MET MET GLY GLU ASP LYS ILE LYS PHE LYS HIS ILE THR SEQRES 7 A 287 PRO LEU GLN GLU GLN SER LYS GLU VAL ALA ILE ARG ILE SEQRES 8 A 287 PHE GLN GLY CYS GLN PHE ARG SER VAL GLU ALA VAL GLN SEQRES 9 A 287 GLU ILE THR GLU TYR ALA LYS SER ILE PRO GLY PHE VAL SEQRES 10 A 287 ASN LEU ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR SEQRES 11 A 287 GLY VAL HIS GLU ILE ILE TYR THR MET LEU ALA SER LEU SEQRES 12 A 287 MET ASN LYS ASP GLY VAL LEU ILE SER GLU GLY GLN GLY SEQRES 13 A 287 PHE MET THR ARG GLU PHE LEU LYS SER LEU ALA LYS PRO SEQRES 14 A 287 PHE GLY ASP PHE MET GLU PRO LYS PHE GLU PHE ALA VAL SEQRES 15 A 287 LYS PHE ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA SEQRES 16 A 287 ILE PHE ILE ALA VAL ILE ILE LEU SER GLY ASP ARG PRO SEQRES 17 A 287 GLY LEU LEU ASN VAL LYS PRO ILE GLU ASP ILE GLN ASP SEQRES 18 A 287 ASN LEU LEU GLN ALA LEU GLU LEU GLN LEU LYS LEU ASN SEQRES 19 A 287 HIS PRO GLU SER SER GLN LEU PHE ALA LYS LEU LEU GLN SEQRES 20 A 287 LYS MET THR ASP LEU ARG GLN ILE VAL THR GLU HIS VAL SEQRES 21 A 287 GLN LEU LEU GLN VAL ILE LYS LYS THR GLU THR ASP MET SEQRES 22 A 287 SER LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP LEU SEQRES 23 A 287 TYR SEQRES 1 B 287 GLY SER HIS MET ALA GLU ILE SER SER ASP ILE ASP GLN SEQRES 2 B 287 LEU ASN PRO GLU SER ALA ASP LEU ARG ALA LEU ALA LYS SEQRES 3 B 287 HIS LEU TYR ASP SER TYR ILE LYS SER PHE PRO LEU THR SEQRES 4 B 287 LYS ALA LYS ALA ARG ALA ILE LEU THR GLY LYS THR THR SEQRES 5 B 287 ASP LYS SER PRO PHE VAL ILE TYR ASP MET ASN SER LEU SEQRES 6 B 287 MET MET GLY GLU ASP LYS ILE LYS PHE LYS HIS ILE THR SEQRES 7 B 287 PRO LEU GLN GLU GLN SER LYS GLU VAL ALA ILE ARG ILE SEQRES 8 B 287 PHE GLN GLY CYS GLN PHE ARG SER VAL GLU ALA VAL GLN SEQRES 9 B 287 GLU ILE THR GLU TYR ALA LYS SER ILE PRO GLY PHE VAL SEQRES 10 B 287 ASN LEU ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR SEQRES 11 B 287 GLY VAL HIS GLU ILE ILE TYR THR MET LEU ALA SER LEU SEQRES 12 B 287 MET ASN LYS ASP GLY VAL LEU ILE SER GLU GLY GLN GLY SEQRES 13 B 287 PHE MET THR ARG GLU PHE LEU LYS SER LEU ALA LYS PRO SEQRES 14 B 287 PHE GLY ASP PHE MET GLU PRO LYS PHE GLU PHE ALA VAL SEQRES 15 B 287 LYS PHE ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA SEQRES 16 B 287 ILE PHE ILE ALA VAL ILE ILE LEU SER GLY ASP ARG PRO SEQRES 17 B 287 GLY LEU LEU ASN VAL LYS PRO ILE GLU ASP ILE GLN ASP SEQRES 18 B 287 ASN LEU LEU GLN ALA LEU GLU LEU GLN LEU LYS LEU ASN SEQRES 19 B 287 HIS PRO GLU SER SER GLN LEU PHE ALA LYS LEU LEU GLN SEQRES 20 B 287 LYS MET THR ASP LEU ARG GLN ILE VAL THR GLU HIS VAL SEQRES 21 B 287 GLN LEU LEU GLN VAL ILE LYS LYS THR GLU THR ASP MET SEQRES 22 B 287 SER LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP LEU SEQRES 23 B 287 TYR HET BRL A 501 25 HET BRL B 501 25 HETNAM BRL 2,4-THIAZOLIDIINEDIONE, 5-[[4-[2-(METHYL-2- HETNAM 2 BRL PYRIDINYLAMINO)ETHOXY]PHENYL]METHYL]-(9CL) HETSYN BRL BRL49653; ROSIGLITAZONE FORMUL 3 BRL 2(C18 H19 N3 O3 S) FORMUL 5 HOH *61(H2 O) HELIX 1 1 GLU A 207 PHE A 226 1 20 HELIX 2 2 THR A 229 THR A 238 1 10 HELIX 3 3 MET A 252 MET A 257 1 6 HELIX 4 4 VAL A 277 SER A 302 1 26 HELIX 5 5 ASP A 310 ALA A 331 1 22 HELIX 6 6 SER A 332 MET A 334 5 3 HELIX 7 7 ARG A 350 LYS A 354 1 5 HELIX 8 8 MET A 364 ALA A 376 1 13 HELIX 9 9 ASP A 380 LEU A 393 1 14 HELIX 10 10 ASN A 402 HIS A 425 1 24 HELIX 11 11 GLN A 430 LYS A 457 1 28 HELIX 12 12 HIS A 466 LYS A 474 1 9 HELIX 13 13 SER B 208 PHE B 226 1 19 HELIX 14 14 THR B 229 THR B 238 1 10 HELIX 15 15 ASP B 251 GLY B 258 1 8 HELIX 16 16 VAL B 277 LYS B 301 1 25 HELIX 17 17 ASN B 312 LEU B 330 1 19 HELIX 18 18 ARG B 350 SER B 355 1 6 HELIX 19 19 PRO B 359 PHE B 363 5 5 HELIX 20 20 MET B 364 LEU B 377 1 14 HELIX 21 21 ASP B 380 LEU B 393 1 14 HELIX 22 22 PRO B 405 HIS B 425 1 21 HELIX 23 23 GLN B 430 LEU B 452 1 23 HELIX 24 24 PRO B 467 LYS B 474 1 8 SHEET 1 A 3 PHE A 247 ILE A 249 0 SHEET 2 A 3 GLY A 346 THR A 349 1 O THR A 349 N ILE A 249 SHEET 3 A 3 GLY A 338 ILE A 341 -1 N ILE A 341 O GLY A 346 SHEET 1 B 3 PHE B 247 ILE B 249 0 SHEET 2 B 3 GLY B 346 THR B 349 1 O PHE B 347 N ILE B 249 SHEET 3 B 3 GLY B 338 ILE B 341 -1 N ILE B 341 O GLY B 346 SITE 1 AC1 10 PHE A 282 CYS A 285 ARG A 288 SER A 289 SITE 2 AC1 10 HIS A 323 VAL A 339 ILE A 341 LEU A 353 SITE 3 AC1 10 HIS A 449 TYR A 473 SITE 1 AC2 16 ILE B 281 PHE B 282 GLY B 284 CYS B 285 SITE 2 AC2 16 SER B 289 HIS B 323 LEU B 330 VAL B 339 SITE 3 AC2 16 ILE B 341 MET B 348 PHE B 363 MET B 364 SITE 4 AC2 16 HIS B 449 LEU B 453 LEU B 469 TYR B 473 CRYST1 85.700 87.100 163.800 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011669 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011481 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006105 0.00000